We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Health benefits

6 November 2019 By Robyn Mak

AstraZeneca is launching a $1 bln healthcare fund in the People’s Republic. A wealthier, older society promises huge growth, but rising costs mean Beijing is pushing drugmakers to lower prices. Investing in local discoveries and exporting them globally could be a smart remedy.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)